Do Analysts Expect Cyteir Therapeutics Inc (CYT) Stock to Rise After It Has Gained 3.49% in a Month?

Tuesday, April 04, 2023 01:18 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Cyteir Therapeutics Inc (CYT) Stock to Rise After It Has Gained 3.49% in a Month?

Analysts who follow Cyteir Therapeutics Inc (CYT) on average expect it to gain 31.07% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Cyteir Therapeutics Inc an Analyst Ranking of 17, which means it ranks higher than 17 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating CYT a Buy today. Find out what this means to you and get the rest of the rankings on CYT!

See Full CYT Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Cyteir Therapeutics Inc Stock Today?

Cyteir Therapeutics Inc (CYT) stock has gained 1.14% while the S&P 500 is lower by -0.61% as of 1:11 PM on Tuesday, Apr 4. CYT has risen $0.02 from the previous closing price of $1.76 on volume of 36,865 shares. Over the past year the S&P 500 has fallen -10.55% while CYT is lower by -59.55%. CYT earned $1.78 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 42.35. Click Here to get the full Stock Report for Cyteir Therapeutics Inc stock.